Amphia — Breda, North Brabant

Public research footprint of Amphia, compiled from the ClinicalTrials.gov public registry.

442

Registered studies

147

Active

Recruiting now

205

Completed

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Carcinoma, Non-Small-Cell Lung · Acute Myeloid Leukemia, Adult · Ischemic Stroke; Ischemic Attack, Transient

Recently updated registry entries

NCT05878769 — A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic… (Recruiting)
NCT06652438 — Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or… (Recruiting)
NCT05889182 — A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Amphia?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.